Heat shock induces HIV-1 replication in chronically infected promyelocyte cell line OM10.1

Arch Virol. 1996;141(3-4):439-47. doi: 10.1007/BF01718308.

Abstract

A long period of clinical latency before development of symptoms is characteristic of human immunodeficiency virus type 1 (HIV-1) infection. OM10.1, a promyelocyte cell line latently infected with HIV-1, has been developed as a model for studying the mechanism of viral latency and the activation of virus expression. We found that this latently infected cell line with heat shock at 42 degrees C for 2 h resulted in a high level of HIV-1 production without addition of any cytokines. The mechanism of activation was analyzed by using anti-TNF-alpha antibody and various inhibitors. Although the TNF-alpha level in culture supernatants was below the sensitivity of an ELISA assay system, addition of anti-TNF-alpha antibody in culture medium could partially suppress the heat shock induced HIV-1 production. Staurosporine (PKC inhibitor), pentoxifylline (NF-kappa B inhibitor), and Ro5-3335 (HIV-1 Tat inhibitor) also inhibited significantly the heat shock induced virus activation. In particular, staurosporine achieved approximately 90% inhibition of the HIV-1 antigen expression in heat shock-treated OM10.1 at a non-toxic concentration. Although the mechanism of HIV-1 activation with heat shock has not been fully elucidated yet, it is presumed PKC plays an important role in HIV-1 activation. Thus, the present observations will provide a further insight into the pathogenesis of HIV-1 infections.

MeSH terms

  • Alkaloids / pharmacology
  • Antibodies / immunology
  • Antiviral Agents / pharmacology
  • Benzodiazepinones / pharmacology
  • Cell Line
  • Enzyme Inhibitors / pharmacology
  • Gene Products, tat / antagonists & inhibitors
  • Granulocytes / virology
  • HIV-1 / drug effects
  • HIV-1 / physiology*
  • Heat-Shock Response*
  • Humans
  • NF-kappa B / antagonists & inhibitors
  • Pentoxifylline / pharmacology
  • Protein Kinase C / antagonists & inhibitors
  • Pyrroles / pharmacology
  • Staurosporine
  • Tumor Necrosis Factor-alpha / immunology
  • Virus Activation* / drug effects
  • Virus Activation* / physiology
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • Alkaloids
  • Antibodies
  • Antiviral Agents
  • Benzodiazepinones
  • Enzyme Inhibitors
  • Gene Products, tat
  • NF-kappa B
  • Pyrroles
  • Tumor Necrosis Factor-alpha
  • tat Gene Products, Human Immunodeficiency Virus
  • Ro 5-3335
  • Protein Kinase C
  • Staurosporine
  • Pentoxifylline